Switch to
More onapp

How to use scorecard? Learn more

Kilitch Drugs (India) Ltd

KILITCH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹563 cr, stock is ranked 1,785
High RiskStock is 3.02x as volatile as Nifty
335.102.55 (-0.76%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹563 cr, stock is ranked 1,785
High RiskStock is 3.02x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
44.75
PB RatioPB Ratio
3.21
Dividend YieldDiv. Yield
Sector PESector PE
51.91
Sector PBSector PB
6.64
Sector Div YldSctr Div Yld
0.47%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.

Financial TrendFinancial statements 

202120222023202471.19117.14142.52158.853.757.3610.4614.60
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnSep 27, 2024

Submitting herewith the scrutinizer reports | Download

Submitting herewith the scrutinizer reports | Download

Shareholders meeting 
Announced OnSep 27, 2024

Kilitch Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2024 | Download

Kilitch Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2024 | Download

Cash Dividend 
Ex. DateSep 20, 2019

Final • Div/Share: ₹ 0.5

See all events